From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA greenlights device for treating carbon monoxide exposure

from MedTech Dive

The FDA has granted De Novo authorization to Canadian startup Thornhill Research's treatment for carbon monoxide poisoning. The ClearMate device is designed to speed the removal of carbon monoxide from the body by delivering 100 percent oxygen and accelerating the patient's rate of breathing. Thornhill showed the device effectively cleared carbon monoxide in 100 patients, leading the FDA to sign off on the product. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063